Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1878, Issue 6, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbcan.2023.189024
Keywords
Apoptosis; Cancer; Cisplatin; Doxorubicin; Etoposide; Gemcitabine; Necroptosis; Paclitaxel; Pyroptosis; 5-fluorouracil
Categories
Ask authors/readers for more resources
This review aims to demonstrate that various FDA-approved chemotherapeutic drugs can induce different types of cell death, providing an overview of their molecular mechanisms and interactions, as well as facilitating the exploration of cell death types induced by other chemotherapeutic agents.
For decades, common chemotherapeutic drugs have been established to trigger apoptosis, the preferred immunologically silent form of cell death. The primary objective of this review was to show that various FDAapproved chemotherapeutic drugs, including cisplatin, cyclosporine, doxorubicin, etoposide, 5-fluorouracil, gemcitabine, paclitaxel, or vinblastine can trigger necroptosis and pyroptosis. We aimed to provide the advantages and disadvantages of the induction of the given type of cell death by chemotherapeutical agents. Moreover, we give a short overview of the molecular mechanism of each type of cell death and indicate the existing crosstalks between cell death types. Finally, we provide a comparison of cell death types to facilitate the exploration of cell death types induced by other chemotherapeutical agents. Understanding the cell death pathway induced by a drug can lessen side effects and assist the discovery of new combinations with synergistic effects and low systemic toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available